An FDA advisory panel concludes that the efficacy of brexpiprazole, when started concurrently with sertraline, has not been ...

This summary covers significant health news including FDA advisers rejecting Otsuka's PTSD treatment, Getinge exceeding ...

The FDA panel voted against Otsuka's PTSD drug combination with Zoloft, questioning its efficacy. Getinge surpassed profit ...

Otsuka and Lundbeck’s data are insufficient to establish significant efficacy of Rexulti plus sertraline in PTSD, according ...

The controversial drugs are not yet approved by federal regulators, but advocates hope a NC law would allow the state to be ...

The administration said it is fast-tracking clinical trials that would allow patients struggling with serious mental health ...

The head of the U.S. Department of Veterans Affairs (VA) is reiterating that he’s “very open” to expanding access to ...

Market is valued at USD 10.25 Billion in 2024 and is projected to reach a value of USD 610.1 Billion by 2035 at a CAGR ...

Proponents of reining in the largely unregulated intoxicating hemp industry in Texas shared new polling data on Wednesday ...

July marks National Minority Mental Health Awareness Month. Black and brown communities often can face specific mental health ...

Boosting the body’s well-being sometimes feels complicated, but some powerful solutions are right inside everyone.

Moderna has scrapped plans to build an mRNA plant in Japan. Otsuka and Lundbeck's proposal for Rexulti as part of a PTSD ...